b.value AG

b.value AG is a German venture and investment firm. The directory entry has limited disclosed data, and the firm’s website (b-value.de) suggests a smaller European fund or family-office-style vehicle investing across European tech and growth opportunities. Healthcare exposure is opportunistic rather than thematic; founders should not assume b.value is a healthcare-specialist firm. Best fit: European, especially German-speaking-region founders looking to add a smaller European check to a round, who would benefit from a German strategic relationship; founders willing to verify the firm’s current investment focus and stage directly via the website before pitching. Entry path is the b.value website and warm intros via the German venture and family-office community. Not appropriate to recommend as a primary check or strategic anchor for healthcare-specific founders without further diligence. Most digital health, biotech, AI healthcare, and medtech founders would be better served by clearly healthcare-focused European funds (Sofinnova, Forbion, LSP, MIG, etc.). The directory listing will be enriched as more data becomes available; in the meantime, founders should prioritize investors with verified healthcare relevance.